End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,820 KRW | -0.51% | 0.00% | -19.63% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 64,680 | 100.0 % | 80,119 | 100.0 % | +23.87% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 64,680 | 100.0 % | 80,119 | 100.0 % | +23.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dae-Young Sung
CEO | Chief Executive Officer | 65 | - |
Kwang-Young Kwon
BRD | Director/Board Member | 63 | - |
Sung-Chul Lee
AUD | Comptroller/Controller/Auditor | 66 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dae-Young Sung
CEO | Chief Executive Officer | 65 | - |
Kwang-Young Kwon
BRD | Director/Board Member | 63 | - |
Yong-Ju Lee
BRD | Director/Board Member | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,202,139 | 6,051,385 ( 45.84 %) | 2,459 ( 0.0186 %) | 45.84 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,459 | 0.02% | 13,746 $ |
Company contact information
WITHUS PHARMACEUTICAL Co., Ltd.
3-5/F, WITHUS Building 9 Dongsan-ro 12-gil
06784, Seoul
+
http://www.withuspharm.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.63% | 74.74M | |
+52.93% | 803B | |
+41.21% | 631B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.72% | 243B | |
+2.21% | 228B | |
+10.31% | 217B | |
+6.24% | 164B |
- Stock Market
- Equities
- A330350 Stock
- Company WITHUS PHARMACEUTICAL Co.,LTD.